Finance

Lists
301393:SHE
Suzhou Highfine Biotech Co Ltd
CNÂ¥56.90
+0.35%
(+0.20) 1D
Sep 3, 3:04:28 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301393...
Open
CNÂ¥56.99
High
CNÂ¥58.24
Low
CNÂ¥56.52
Mkt. cap
6.12B
Avg. vol.
3.06M
Volume
2.42M
Dividend
0.71%
Quarterly dividend
CNÂ¥0.10
Ex-dividend date
May 21, 2026
P/E ratio
55.94
52-wk high
CNÂ¥74.68
52-wk low
CNÂ¥46.69
EPS
CNÂ¥1.02
Shares outstanding
108.00M
No. of employees
678
Open
CNÂ¥56.99
High
CNÂ¥58.24
Low
CNÂ¥56.52
Mkt. cap
6.12B
Avg. vol.
3.06M
Volume
2.42M
Dividend
0.71%
Quarterly dividend
CNÂ¥0.10
Ex-dividend date
May 21, 2026
P/E ratio
55.94
52-wk high
CNÂ¥74.68
52-wk low
CNÂ¥46.69
EPS
CNÂ¥1.02
Shares outstanding
108.00M
No. of employees
678
About Suzhou Highfine Biotech Co Ltd
CEO-
Employees678
FoundedDec 2, 2003
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
164.40M
167.56M
171.93M
207.29M
Cost of goods sold
104.78M
132.84M
110.89M
134.04M
Cost of revenue
104.78M
132.84M
110.89M
134.04M
Research and development expenses
11.35M
10.32M
10.69M
12.65M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
20.49M
9.78M
16.37M
16.91M
Operating expense
24.71M
31.28M
28.58M
29.22M
Total operating expenses
129.48M
164.13M
139.47M
163.26M
Operating income
34.92M
3.43M
32.47M
44.03M
Other non operating income
-5.48M
6.81M
-3.34M
-2.74M
EBT including unusual items
26.71M
15.44M
37.63M
43.82M
EBT excluding unusual items
38.29M
11.00M
32.52M
40.00M
Income tax expense
3.35M
3.84M
4.92M
7.15M
Effective tax rate
12.56%
24.85%
13.06%
16.31%
Other operating expenses
-2.35M
7.73M
433.75K
748.71K
Net income
23.35M
15.41M
33.44M
37.30M
Net profit margin
14.21%
9.20%
19.45%
17.99%
Earnings per share
-
-
-
-
Interest and investment income
7.95M
8.28M
3.55M
152.49K
Interest expense
-454.89K
-193.75K
-152.49K
-1.44M
Net interest expenses
7.49M
8.09M
3.40M
-1.29M
Depreciation and amortization charges
-
-
-
-
EBITDA
39.48M
12.45M
41.48M
54.51M
Gain or loss from assets sale
-93.99K
907.51K
-
-124.54K
AI content may include mistakes. Learn more
Google apps